2025年全球诊断放射性同位素市场报告

预计未来几年诊断放射性同位素市场规模将强劲成长。到 2029 年，这一数字将成长至 88.3 亿美元，复合年增长率为 9.7%。预测期内的成长可归因于新的放射性同位素生产方法、不断扩大的临床应用、以患者为中心的护理和安全、即时护理成像、环境永续性和绿色化学。预测期内的关键趋势包括混合成像技术、治疗诊断学、分子成像技术、迴旋加速器或发生器的使用、安全性和辐射防护等。

癌症负担的增加预计将推动诊断放射性同位素市场的扩张。癌症是一种以异常细胞不受控制地分裂并损害周围组织为特征的疾病。癌症发生率的上升可归因于多种因素，包括吸烟、肥胖和缺乏运动等生活方式选择、接触致癌物质、遗传因素和环境影响。放射性同位素在癌症管理中发挥着至关重要的作用，它可以提供准确的诊断、实现有针对性的治疗，并有助于有效监测癌症进展和治疗反应。例如，2024年5月，美国专注于癌症研究和培训的政府机构国家癌症研究所预测，到2040年，全球每年新发癌症病例将达到2990万，癌症相关死亡人数将达到1530万。因此，癌症负担的增加正在推动诊断放射性同位素市场的成长。

诊断放射性同位素市场的主要企业正专注于放射性药物技术的进步，以提高诊断准确性、改善患者预后并扩大核医学在医疗保健中的应用。先进的放射性药物技术涉及开发用于核医学精确成像和标靶治疗的创新化合物和技术。例如，义大利诊断影像公司 Bracco Group 于 2022 年 3 月推出了子公司 Blue Earth Therapeutics，专门开发下一代治疗性放射性药物技术，最初针对摄护腺癌，并计划进一步扩展到其他癌症领域。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场－宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球诊断放射性同位素 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球诊断放射性同位素市场：成长率分析
• 全球诊断放射性同位素市场表现：规模与成长，2019-2024
• 全球诊断放射性同位素市场预测：2024-2029 年及 2034 年规模与成长
• 全球诊断放射性同位素总目标市场（TAM）

第六章市场区隔

• 全球诊断放射性同位素市场（以放射性同位素划分）现况及预测（2019-2024 年、2024-2029 年、2034 年）
• Technetium-99m
• 铊-201
• 镓-67
• 碘-123
• 氟脱氧葡萄糖（FDG）
• 铷82
• 其他放射性同位素
• 全球诊断放射性同位素市场（依影像方式、效能与预测），2019-2024 年、2024-2029 年、2034 年
• 单光子发射电脑断层扫描（SPECT）
• 正子断层扫描（PET）
• β射线发射器
• 全球诊断放射性同位素市场的应用、性能和预测（2019-2024 年、2024-2029 年和 2034 年）
• 肿瘤学
• 心臟病学
• 其他用途
• 全球诊断放射性同位素市场（按最终用户、绩效和预测）2019-2024 年、2024-2029 年、2034 年
• 医院
• 专科诊所
• 诊断中心
• 学术研究所
• 其他最终用户
• 全球诊断放射性同位素市场Technetium99m细分市场（按类型、性能和预测），2019-2024年，2024-2029年，2034年
• 诊断影像
• 心臟影像
• 肿瘤影像
• 骨骼扫描
• 肾臟扫描
• 全球诊断放射性同位素市场铊201细分市场（按类型、实际及预测），2019-2024年，2024-2029年，2034年
• 心臟影像
• 心肌灌注显像
• 压力测试
• 全球诊断放射性同位素市场、镓-67细分市场、按类型、绩效及预测（2019-2024年、2024-2029年及2034年）
• 肿瘤影像诊断（淋巴瘤、肿瘤）
• 发炎性疾病的影像诊断
• 感染影像诊断
• 全球诊断放射性同位素市场碘-123细分市场（按类型、性能和预测），2019-2024年，2024-2029年，2034年
• 甲状腺影像检查
• 神经影像检查（帕金森氏症）
• 心臟影像
• 全球诊断放射性同位素市场，依氟脱氧葡萄糖 (FDG) 类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 正子断层扫描（PET）影像
• 癌症诊断和分期
• 神经影像学
• 心臟影像
• 全球诊断放射性同位素市场铷82细分市场（按类型、性能和预测），2019-2024年，2024-2029年，2034年
• 心臟PET成像
• 心肌灌注显像
• 冠状动脉疾病的诊断
• 全球诊断放射性同位素市场其他放射性同位素细分市场（按类型、实际和预测），2019-2024 年、2024-2029 年、2034 年
• 锶89（用于缓解骨痛）
• 碘131（用于治疗甲状腺癌）
• 钐153（缓解骨痛）
• 钇90（癌症治疗）

第七章 区域和国家分析

• 全球诊断放射性同位素市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
• 全球诊断放射性同位素市场：依国家、绩效与预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 诊断放射性同位素市场：竞争格局
• 诊断放射性同位素市场：公司简介
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • BWX Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lantheus Holdings Overview, Products and Services, Strategy and Financial Analysis
  • Curium Pharma Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Clarity Pharmaceuticals
• Bracco Diagnostic Inc.
• Ion Beam Applications SA
• Nordion Inc.
• Eckert & Ziegler AG
• NorthStar Medical Radioisotopes LLC
• NTP Radioisotopes SOC Ltd
• Global Medical Solutions Ltd.
• Isotopia Molecular Imaging Ltd.
• Cyclopharm Limited
• Trasis NV
• Orano Med LLC
• ARTMS Inc.
• Radiomedix Inc.
• Coqu RadioPharmaceuticals Corp.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年诊断放射性同位素市场：提供新机会的国家
• 2029年诊断放射性同位素市场：细分市场带来新机会
• 2029年诊断放射性同位素市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Diagnostic radioisotopes are radioactive isotopes employed in nuclear medicine for diagnosing and monitoring diverse medical conditions. They rely on their radioactive decay characteristics to emit radiation, detected by specialized imaging tools, enabling healthcare providers to acquire detailed internal body structure images and evaluate their function.

The primary diagnostic radioisotopes include technetium-99m, thallium-201, gallium-67, iodine-123, fluorodeoxyglucose (FDG), rubidium-82, and others. Technetium-99m is extensively used in medical imaging due to its advantageous nuclear properties and wide accessibility. Imaging techniques include single photon emission computed tomography (SPECT), positron emission tomography (PET), and beta emitters, employed across various fields such as oncology and cardiology.

The diagnostic radioisotopes research report is one of a series of new reports from The Business Research Company that provides diagnostic radioisotopes market statistics, including the diagnostic radioisotopes industry's global market size, regional shares, competitors with a diagnostic radioisotopes market share, detailed diagnostic radioisotopes market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic radioisotopes industry. This diagnostic radioisotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diagnostic radioisotopes market size has grown rapidly in recent years. It will grow from $5.54 billion in 2024 to $6.1 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to the discovery of radioactivity, the introduction of technetium-99m, clinical applications and research, cold war era and nuclear research, and emergence of positron emission tomography.

The diagnostic radioisotopes market size is expected to see strong growth in the next few years. It will grow to $8.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emerging radioisotope production methods, expanded clinical applications, patient-centered care and safety, point-of-care imaging and environmental sustainability and green chemistry. Major trends in the forecast period include hybrid imaging techniques, theranostics, molecular imaging techniques, the use of cyclotrons or generators, and safety and radiation protection.

The growing burden of cancer is expected to drive the expansion of the diagnostic radioisotopes market. Cancer is a disease characterized by the uncontrolled division of abnormal cells that damage surrounding tissue. The increasing prevalence of cancer is attributed to various factors, including lifestyle choices such as smoking, obesity, lack of physical activity, exposure to carcinogens, genetic factors, and environmental influences. Radioisotopes play a crucial role in cancer management by providing accurate diagnosis, enabling targeted treatments, and facilitating effective monitoring of cancer progression or response to therapy. For example, in May 2024, the National Cancer Institute, a US-based government agency focused on cancer research and training, projected that by 2040, the global number of new cancer cases per year will reach 29.9 million, with 15.3 million cancer-related deaths. As a result, the rising burden of cancer is driving the growth of the diagnostic radioisotopes market.

Key players in the diagnostic radioisotopes market are focused on advancing radiopharmaceutical technology to enhance diagnostic accuracy, improve patient outcomes, and expand the applications of nuclear medicine in healthcare. Advanced radiopharmaceutical technology involves the development of innovative compounds and techniques for precise imaging and targeted therapy in nuclear medicine. For example, Bracco Group, an Italy-based diagnostic imaging company, launched Blue Earth Therapeutics in March 2022, a subsidiary dedicated to advancing next-generation therapeutic radiopharmaceutical technology, initially targeting prostate cancer with plans for further expansion into other oncology areas.

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired ARTMS to strengthen its supply chain and manufacturing capabilities. This acquisition aims to leverage ARTMS' expertise in cyclotron-based isotope production to enhance market position and meet the growing demand for diagnostic and therapeutic isotopes. ARTMS, headquartered in Canada, specializes in radioisotope technology and is a leading provider of diagnostic radioisotopes.

Major companies operating in the diagnostic radioisotopes market are Cardinal Health Inc., Sumitomo Heavy Industries Ltd., BWX Technologies Inc., Lantheus Holdings, Curium Pharma, Clarity Pharmaceuticals, Bracco Diagnostic Inc., Ion Beam Applications S.A., Nordion Inc., Eckert & Ziegler AG, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Global Medical Solutions Ltd., Isotopia Molecular Imaging Ltd., Cyclopharm Limited, Trasis NV, Orano Med LLC, ARTMS Inc., Radiomedix Inc., Coqu RadioPharmaceuticals Corp., IsoTherapeutics Group LLC

North America was the largest region in the diagnostic radioisotopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic radioisotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic radioisotopes market consists of revenues earned by entities by providing services such as radiopharmacy services, imaging services, radioisotope production and supply, diagnostic procedures, and theranostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic radioisotopes market also includes sales of products including Indium-111, Xenon-133, Molybdenum-99, and Phosphorus-32. Values in this market are 'factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostic Radioisotopes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostic radioisotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostic radioisotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diagnostic radioisotopes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Radioisotope: Technetium-99m; Thallium-201; Gallium-67; Iodine-123; FluoroDeoxyGlucose (FDG); Rubidium-82; Other Radioisotopes
• 2) By Imaging Modality: Single Photon Emission Computed Tomography (SPECT); Positron Emission Tomography (PET); Beta Emitters
• 3) By Application: Oncology; Cardiology; Other Applications
• 4) By End User: Hospitals; Specialty Clinics; Diagnostic Centers; Academic And Research Institutes; Other End Users
• Subsegments:
• 1) By Technetium-99m: Diagnostic Imaging; Cardiac Imaging; Oncology Imaging; Bone Scans; Renal Scans
• 2) By Thallium-201: Cardiac Imaging; Myocardial Perfusion Imaging; Stress Tests
• 3) By Gallium-67: Oncology Imaging (Lymphoma, Tumors); Inflammatory Disease Imaging; Infection Imaging
• 4) By Iodine-123: Thyroid Imaging; Neurological Imaging (Parkinson's Disease); Cardiac Imaging
• 5) By FluoroDeoxyGlucose (FDG): Positron Emission Tomography (PET) Imaging; Cancer Diagnosis And Staging; Neurological Imaging; Cardiac Imaging
• 6) By Rubidium-82: Cardiac PET Imaging; Myocardial Perfusion Imaging; Coronary Artery Disease Diagnosis
• 7) By Other Radioisotopes: Strontium-89 (Bone Pain Palliation); Iodine-131 (Thyroid Cancer Treatment); Samarium-153 (Bone Pain Palliation); Yttrium-90 (Cancer Treatment)
• Companies Mentioned: Cardinal Health Inc.; Sumitomo Heavy Industries Ltd.; BWX Technologies Inc.; Lantheus Holdings; Curium Pharma
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diagnostic Radioisotopes market Characteristics

3. Diagnostic Radioisotopes market Trends And Strategies

4. Diagnostic Radioisotopes market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Diagnostic Radioisotopes Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diagnostic Radioisotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diagnostic Radioisotopes market Growth Rate Analysis
• 5.4. Global Diagnostic Radioisotopes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diagnostic Radioisotopes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diagnostic Radioisotopes Total Addressable Market (TAM)

6. Diagnostic Radioisotopes market Segmentation

• 6.1. Global Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Technetium-99m
• Thallium-201
• Gallium-67
• Iodine-123
• FluoroDeoxyGlucose (FDG)
• Rubidium-82
• Other Radioisotopes
• 6.2. Global Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Photon Emission Computed Tomography (SPECT)
• Positron Emission Tomography (PET)
• Beta Emitters
• 6.3. Global Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiology
• Other Applications
• 6.4. Global Diagnostic Radioisotopes market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Academic And Research Institutes
• Other End Users
• 6.5. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Technetium-99m, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Imaging
• Cardiac Imaging
• Oncology Imaging
• Bone Scans
• Renal Scans
• 6.6. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Thallium-201, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Imaging
• Myocardial Perfusion Imaging
• Stress Tests
• 6.7. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Gallium-67, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology Imaging (Lymphoma, Tumors)
• Inflammatory Disease Imaging
• Infection Imaging
• 6.8. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Iodine-123, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thyroid Imaging
• Neurological Imaging (Parkinson's Disease)
• Cardiac Imaging
• 6.9. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of FluoroDeoxyGlucose (FDG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Positron Emission Tomography (PET) Imaging
• Cancer Diagnosis And Staging
• Neurological Imaging
• Cardiac Imaging
• 6.10. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Rubidium-82, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac PET Imaging
• Myocardial Perfusion Imaging
• Coronary Artery Disease Diagnosis
• 6.11. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Other Radioisotopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Strontium-89 (Bone Pain Palliation)
• Iodine-131 (Thyroid Cancer Treatment)
• Samarium-153 (Bone Pain Palliation)
• Yttrium-90 (Cancer Treatment)

7. Diagnostic Radioisotopes market Regional And Country Analysis

• 7.1. Global Diagnostic Radioisotopes market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diagnostic Radioisotopes market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diagnostic Radioisotopes market

• 8.1. Asia-Pacific Diagnostic Radioisotopes market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diagnostic Radioisotopes market

• 9.1. China Diagnostic Radioisotopes market Overview
• 9.2. China Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diagnostic Radioisotopes market

• 10.1. India Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diagnostic Radioisotopes market

• 11.1. Japan Diagnostic Radioisotopes market Overview
• 11.2. Japan Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diagnostic Radioisotopes market

• 12.1. Australia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diagnostic Radioisotopes market

• 13.1. Indonesia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diagnostic Radioisotopes market

• 14.1. South Korea Diagnostic Radioisotopes market Overview
• 14.2. South Korea Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diagnostic Radioisotopes market

• 15.1. Western Europe Diagnostic Radioisotopes market Overview
• 15.2. Western Europe Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diagnostic Radioisotopes market

• 16.1. UK Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diagnostic Radioisotopes market

• 17.1. Germany Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diagnostic Radioisotopes market

• 18.1. France Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diagnostic Radioisotopes market

• 19.1. Italy Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diagnostic Radioisotopes market

• 20.1. Spain Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diagnostic Radioisotopes market

• 21.1. Eastern Europe Diagnostic Radioisotopes market Overview
• 21.2. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diagnostic Radioisotopes market

• 22.1. Russia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diagnostic Radioisotopes market

• 23.1. North America Diagnostic Radioisotopes market Overview
• 23.2. North America Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diagnostic Radioisotopes market

• 24.1. USA Diagnostic Radioisotopes market Overview
• 24.2. USA Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diagnostic Radioisotopes market

• 25.1. Canada Diagnostic Radioisotopes market Overview
• 25.2. Canada Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diagnostic Radioisotopes market

• 26.1. South America Diagnostic Radioisotopes market Overview
• 26.2. South America Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diagnostic Radioisotopes market

• 27.1. Brazil Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diagnostic Radioisotopes market

• 28.1. Middle East Diagnostic Radioisotopes market Overview
• 28.2. Middle East Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diagnostic Radioisotopes market

• 29.1. Africa Diagnostic Radioisotopes market Overview
• 29.2. Africa Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diagnostic Radioisotopes market Competitive Landscape And Company Profiles

• 30.1. Diagnostic Radioisotopes market Competitive Landscape
• 30.2. Diagnostic Radioisotopes market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. BWX Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lantheus Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Diagnostic Radioisotopes market Other Major And Innovative Companies

• 31.1. Clarity Pharmaceuticals
• 31.2. Bracco Diagnostic Inc.
• 31.3. Ion Beam Applications S.A.
• 31.4. Nordion Inc.
• 31.5. Eckert & Ziegler AG
• 31.6. NorthStar Medical Radioisotopes LLC
• 31.7. NTP Radioisotopes SOC Ltd
• 31.8. Global Medical Solutions Ltd.
• 31.9. Isotopia Molecular Imaging Ltd.
• 31.10. Cyclopharm Limited
• 31.11. Trasis NV
• 31.12. Orano Med LLC
• 31.13. ARTMS Inc.
• 31.14. Radiomedix Inc.
• 31.15. Coqu RadioPharmaceuticals Corp.

32. Global Diagnostic Radioisotopes market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diagnostic Radioisotopes market

34. Recent Developments In The Diagnostic Radioisotopes market

35. Diagnostic Radioisotopes market High Potential Countries, Segments and Strategies

• 35.1 Diagnostic Radioisotopes market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diagnostic Radioisotopes market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diagnostic Radioisotopes market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer